Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Eric J. Lenze |
Documentos disponibles escritos por este autor (4)
Refinar búsquedaAugmenting computerized cognitive training with vortioxetine for age-related cognitive decline / Eric J. Lenze en The American Journal of Psychiatry, Año 2020 - Vol. 177 - No. 6 (Junio)
Título : Augmenting computerized cognitive training with vortioxetine for age-related cognitive decline : a randomized controlled trial Tipo de documento: texto impreso Autores: Eric J. Lenze, Autor ; Angela Stevens, Autor ; Jill D. Waring, Autor Fecha de publicación: 2020 Artículo en la página: pp. 548-555 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Declive cognitivo, Entrenamiento cognitivo, Antidepresivos, Neuroplasticidad, Intervenciones cognitivas, Estrategias de combinación Resumen: Age-related cognitive decline, the deterioration in functions such as memory and executive function, is faced by most older adults and affects function and quality of life. No approved treatments exist for age-related cognitive decline. Computerized cognitive training has been shown to provide consistent albeit modest improvements in cognitive function as measured by neuropsychological testing. Link: ./index.php?lvl=notice_display&id=23957
in The American Journal of Psychiatry > Año 2020 - Vol. 177 - No. 6 (Junio) . - pp. 548-555[artículo] Augmenting computerized cognitive training with vortioxetine for age-related cognitive decline : a randomized controlled trial [texto impreso] / Eric J. Lenze, Autor ; Angela Stevens, Autor ; Jill D. Waring, Autor . - 2020 . - pp. 548-555.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The American Journal of Psychiatry > Año 2020 - Vol. 177 - No. 6 (Junio) . - pp. 548-555
Palabras clave: Declive cognitivo, Entrenamiento cognitivo, Antidepresivos, Neuroplasticidad, Intervenciones cognitivas, Estrategias de combinación Resumen: Age-related cognitive decline, the deterioration in functions such as memory and executive function, is faced by most older adults and affects function and quality of life. No approved treatments exist for age-related cognitive decline. Computerized cognitive training has been shown to provide consistent albeit modest improvements in cognitive function as measured by neuropsychological testing. Link: ./index.php?lvl=notice_display&id=23957
Título : Evidence-based treatment of geriatric anxiety disorders Tipo de documento: texto impreso Autores: Julie Loebach Wetherell, Autor ; Eric J. Lenze, Autor ; Melinda A. Stanley, Autor Fecha de publicación: 2020 Artículo en la página: pp. 871-896 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Agentes ansiolíticos, Trastornos de ansiedad, Métodos de terapia cognitivo-conductual, Terapia de modalidad combinada, Servicios de salud para personas mayores, Servicios de salud mental, Trastorno obsesivo-compulsivo, Trastorno de pánico. Resumen: Available data point to the potential value of pharmacologic and cognitive-behavioral interventions for the treatment of late-life anxiety disorders, with modest improvement and response rates in most cases. Further efficacy work is needed to investigate the impact of improved psychosocial approaches that allow for more idiosyncratic attention to the needs of older patients and outcomes following a broader range of pharmacologic treatments. Link: ./index.php?lvl=notice_display&id=24639
in Psychiatric Clinics of North America > Año 2005 - Vol. 28 No. 4 (Diciembre) . - pp. 871-896[artículo] Evidence-based treatment of geriatric anxiety disorders [texto impreso] / Julie Loebach Wetherell, Autor ; Eric J. Lenze, Autor ; Melinda A. Stanley, Autor . - 2020 . - pp. 871-896.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Psychiatric Clinics of North America > Año 2005 - Vol. 28 No. 4 (Diciembre) . - pp. 871-896
Palabras clave: Agentes ansiolíticos, Trastornos de ansiedad, Métodos de terapia cognitivo-conductual, Terapia de modalidad combinada, Servicios de salud para personas mayores, Servicios de salud mental, Trastorno obsesivo-compulsivo, Trastorno de pánico. Resumen: Available data point to the potential value of pharmacologic and cognitive-behavioral interventions for the treatment of late-life anxiety disorders, with modest improvement and response rates in most cases. Further efficacy work is needed to investigate the impact of improved psychosocial approaches that allow for more idiosyncratic attention to the needs of older patients and outcomes following a broader range of pharmacologic treatments. Link: ./index.php?lvl=notice_display&id=24639
Título : Incomplete response in late life depression : getting to remission Tipo de documento: texto impreso Autores: Eric J. Lenze, Autor ; Meera Sheffrin, Autor ; Henry C. Driscoll, Autor Fecha de publicación: 2022 Artículo en la página: pp. 419–430 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Depresión en la vejez, Respuesta incompleta, Remisión, Potenciación farmacológica, Aripiprazol Resumen: Incomplete response in the treatmen tof late-life depression is a large public health challenge: at least 50% of older people fail to respond adequately to first-line antidepressant pharmacotherapy, even under optimal treatment conditions. Treatment-resistant late-life depression (TRLLD) increases risk for early relapse, undermines adherence to treatment for coexisting medical disorders, amplifies disability and cognitive impairment,... Link: ./index.php?lvl=notice_display&id=28731
in Dialogues in Clinical Neuroscience > Año 2008 Vol.10 - No.4 (Diciembre) . - pp. 419–430[artículo] Incomplete response in late life depression : getting to remission [texto impreso] / Eric J. Lenze, Autor ; Meera Sheffrin, Autor ; Henry C. Driscoll, Autor . - 2022 . - pp. 419–430.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Dialogues in Clinical Neuroscience > Año 2008 Vol.10 - No.4 (Diciembre) . - pp. 419–430
Palabras clave: Depresión en la vejez, Respuesta incompleta, Remisión, Potenciación farmacológica, Aripiprazol Resumen: Incomplete response in the treatmen tof late-life depression is a large public health challenge: at least 50% of older people fail to respond adequately to first-line antidepressant pharmacotherapy, even under optimal treatment conditions. Treatment-resistant late-life depression (TRLLD) increases risk for early relapse, undermines adherence to treatment for coexisting medical disorders, amplifies disability and cognitive impairment,... Link: ./index.php?lvl=notice_display&id=28731
Título : Relation of serotonin transporter genetic variation to efficacy of escitalopram for generalized anxiety disorder in older adults Tipo de documento: texto impreso Autores: Eric J. Lenze, Autor ; Alison M. Goate, Autor ; Petra Nowotny, Autor Fecha de publicación: 2022 Artículo en la página: pp. 672-677 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Geriatría, Trastornos de ansiedad, Genética, ISRS Resumen: Generalized anxiety disorder (GAD) is common in older adults and can be treated with selective serotonin reuptake inhibitors (SSRIs). Genetic variation in the serotonin transporter gene promoter region is posited to be associated with SSRI efficacy: 2 polymorphisms (5-HTTLPR S/L and rs25531 g/a) form a haplotype with the La combination having higher transcription activity than other haplotypes. Link: ./index.php?lvl=notice_display&id=29414
in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 6 (Diciembre) . - pp. 672-677[artículo] Relation of serotonin transporter genetic variation to efficacy of escitalopram for generalized anxiety disorder in older adults [texto impreso] / Eric J. Lenze, Autor ; Alison M. Goate, Autor ; Petra Nowotny, Autor . - 2022 . - pp. 672-677.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 6 (Diciembre) . - pp. 672-677
Palabras clave: Geriatría, Trastornos de ansiedad, Genética, ISRS Resumen: Generalized anxiety disorder (GAD) is common in older adults and can be treated with selective serotonin reuptake inhibitors (SSRIs). Genetic variation in the serotonin transporter gene promoter region is posited to be associated with SSRI efficacy: 2 polymorphisms (5-HTTLPR S/L and rs25531 g/a) form a haplotype with the La combination having higher transcription activity than other haplotypes. Link: ./index.php?lvl=notice_display&id=29414
